Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Genomics | 14 | 2022 | 5929 | 2.250 |
Why?
|
Pathology | 5 | 2018 | 270 | 1.990 |
Why?
|
Pathology, Molecular | 4 | 2021 | 330 | 1.870 |
Why?
|
Blood Transfusion | 13 | 2024 | 1297 | 1.470 |
Why?
|
Internship and Residency | 11 | 2022 | 5946 | 1.210 |
Why?
|
Education, Medical, Graduate | 4 | 2021 | 2418 | 1.040 |
Why?
|
Erythrocyte Transfusion | 5 | 2023 | 568 | 1.040 |
Why?
|
Cord Blood Stem Cell Transplantation | 7 | 2016 | 316 | 1.030 |
Why?
|
Educational Measurement | 5 | 2021 | 1260 | 0.960 |
Why?
|
Erythroblastosis, Fetal | 3 | 2022 | 62 | 0.950 |
Why?
|
Curriculum | 13 | 2022 | 3782 | 0.900 |
Why?
|
Pathology, Clinical | 4 | 2012 | 377 | 0.900 |
Why?
|
Blood Group Antigens | 2 | 2023 | 183 | 0.830 |
Why?
|
Antigens, CD34 | 1 | 2024 | 656 | 0.770 |
Why?
|
Rh-Hr Blood-Group System | 2 | 2015 | 64 | 0.720 |
Why?
|
Blood Grouping and Crossmatching | 4 | 2022 | 99 | 0.710 |
Why?
|
Hemolysis | 1 | 2022 | 406 | 0.700 |
Why?
|
Isoantibodies | 5 | 2022 | 681 | 0.640 |
Why?
|
Blood Banks | 2 | 2010 | 108 | 0.620 |
Why?
|
Hematologic Diseases | 1 | 2022 | 500 | 0.620 |
Why?
|
Physicians | 7 | 2021 | 4588 | 0.590 |
Why?
|
Rho(D) Immune Globulin | 4 | 2022 | 34 | 0.580 |
Why?
|
Medical Oncology | 3 | 2021 | 2339 | 0.570 |
Why?
|
Rh Isoimmunization | 2 | 2015 | 23 | 0.550 |
Why?
|
Hospitalists | 1 | 2021 | 297 | 0.550 |
Why?
|
Problem-Based Learning | 2 | 2018 | 360 | 0.510 |
Why?
|
Fetal Blood | 5 | 2016 | 1369 | 0.510 |
Why?
|
Bone Marrow Transplantation | 1 | 2023 | 2729 | 0.490 |
Why?
|
Hematologic Neoplasms | 2 | 2024 | 1927 | 0.430 |
Why?
|
Graft vs Host Disease | 4 | 2024 | 3078 | 0.420 |
Why?
|
Blood Specimen Collection | 2 | 2016 | 238 | 0.410 |
Why?
|
Clinical Competence | 11 | 2022 | 4863 | 0.400 |
Why?
|
Clinical Audit | 1 | 2011 | 29 | 0.370 |
Why?
|
Hematopoietic Stem Cell Transplantation | 4 | 2024 | 5753 | 0.370 |
Why?
|
Education, Medical, Undergraduate | 2 | 2018 | 1085 | 0.360 |
Why?
|
Emergency Medical Services | 1 | 2022 | 1938 | 0.360 |
Why?
|
Plasma Exchange | 1 | 2011 | 160 | 0.350 |
Why?
|
Blood Component Transfusion | 1 | 2011 | 138 | 0.350 |
Why?
|
Erythrocytes | 5 | 2023 | 2395 | 0.340 |
Why?
|
Platelet Transfusion | 3 | 2013 | 296 | 0.340 |
Why?
|
Needs Assessment | 5 | 2021 | 1138 | 0.340 |
Why?
|
Medical Records | 1 | 2015 | 1409 | 0.340 |
Why?
|
Pregnancy Complications | 3 | 2015 | 2971 | 0.320 |
Why?
|
Blood Group Incompatibility | 2 | 2023 | 134 | 0.310 |
Why?
|
Graft Survival | 4 | 2009 | 3890 | 0.300 |
Why?
|
Healthcare Disparities | 1 | 2024 | 3412 | 0.300 |
Why?
|
Laboratories, Hospital | 1 | 2009 | 193 | 0.290 |
Why?
|
Internal Medicine | 1 | 2014 | 1064 | 0.280 |
Why?
|
Boronic Acids | 1 | 2011 | 916 | 0.280 |
Why?
|
Hemoglobinuria, Paroxysmal | 1 | 2008 | 86 | 0.280 |
Why?
|
Humans | 66 | 2024 | 765956 | 0.270 |
Why?
|
Quality Control | 1 | 2010 | 837 | 0.270 |
Why?
|
Vitamin K Deficiency Bleeding | 1 | 2006 | 9 | 0.260 |
Why?
|
Protein Tyrosine Phosphatases | 2 | 1999 | 457 | 0.260 |
Why?
|
Multiple Myeloma | 3 | 2020 | 5197 | 0.250 |
Why?
|
ABO Blood-Group System | 3 | 2023 | 380 | 0.250 |
Why?
|
Pyrazines | 1 | 2011 | 1204 | 0.250 |
Why?
|
Transplantation, Homologous | 3 | 2024 | 4860 | 0.250 |
Why?
|
Computer Simulation | 1 | 2018 | 6255 | 0.240 |
Why?
|
Trans-Activators | 6 | 2007 | 2850 | 0.240 |
Why?
|
Metalloendopeptidases | 2 | 2014 | 386 | 0.240 |
Why?
|
Cell Separation | 2 | 2016 | 1718 | 0.230 |
Why?
|
Hemolytic-Uremic Syndrome | 1 | 2005 | 105 | 0.230 |
Why?
|
Education | 2 | 2017 | 533 | 0.220 |
Why?
|
Purpura, Thrombotic Thrombocytopenic | 1 | 2005 | 132 | 0.210 |
Why?
|
Blood Transfusion, Intrauterine | 1 | 2022 | 28 | 0.210 |
Why?
|
Exchange Transfusion, Whole Blood | 1 | 2022 | 59 | 0.200 |
Why?
|
Hematopoietic Stem Cells | 2 | 2020 | 3401 | 0.200 |
Why?
|
Blood Component Removal | 1 | 2022 | 124 | 0.190 |
Why?
|
von Willebrand Factor | 1 | 2005 | 676 | 0.180 |
Why?
|
Evidence-Based Medicine | 2 | 2010 | 3685 | 0.180 |
Why?
|
Schools, Medical | 2 | 2021 | 876 | 0.180 |
Why?
|
Cell Nucleus | 3 | 1999 | 2867 | 0.170 |
Why?
|
Online Systems | 1 | 2020 | 181 | 0.170 |
Why?
|
Review Literature as Topic | 3 | 2011 | 297 | 0.160 |
Why?
|
Acute Kidney Injury | 1 | 2011 | 1946 | 0.160 |
Why?
|
Education, Medical | 2 | 2010 | 1746 | 0.150 |
Why?
|
Vulnerable Populations | 1 | 2023 | 718 | 0.140 |
Why?
|
Membrane Transport Proteins | 1 | 2023 | 1028 | 0.140 |
Why?
|
DNA-Binding Proteins | 6 | 2004 | 9601 | 0.140 |
Why?
|
Biomedical Research | 2 | 2017 | 3458 | 0.130 |
Why?
|
Antibodies, Monoclonal | 2 | 2015 | 9249 | 0.130 |
Why?
|
Transplantation, Autologous | 1 | 2020 | 2120 | 0.120 |
Why?
|
Preceptorship | 1 | 2016 | 57 | 0.120 |
Why?
|
National Cancer Institute (U.S.) | 1 | 2017 | 299 | 0.120 |
Why?
|
Financing, Organized | 1 | 2017 | 201 | 0.120 |
Why?
|
Data Collection | 2 | 2014 | 3318 | 0.120 |
Why?
|
Models, Educational | 1 | 2018 | 376 | 0.120 |
Why?
|
Fetus | 1 | 2022 | 1878 | 0.120 |
Why?
|
von Willebrand Diseases | 1 | 2017 | 135 | 0.120 |
Why?
|
Kell Blood-Group System | 1 | 2014 | 21 | 0.120 |
Why?
|
Transplantation Chimera | 2 | 2007 | 609 | 0.120 |
Why?
|
Infant, Newborn | 5 | 2022 | 26349 | 0.110 |
Why?
|
Thrombelastography | 1 | 2017 | 193 | 0.110 |
Why?
|
False Negative Reactions | 1 | 2015 | 573 | 0.110 |
Why?
|
Educational Status | 1 | 2021 | 2513 | 0.110 |
Why?
|
Microbiological Techniques | 1 | 2014 | 96 | 0.110 |
Why?
|
Anesthesiology | 1 | 2022 | 1135 | 0.100 |
Why?
|
Blood Preservation | 1 | 2013 | 168 | 0.100 |
Why?
|
Hematology | 1 | 2015 | 243 | 0.100 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2014 | 3655 | 0.100 |
Why?
|
Anesthesia | 1 | 2022 | 1590 | 0.090 |
Why?
|
Antineoplastic Agents | 2 | 2011 | 13648 | 0.090 |
Why?
|
Australia | 1 | 2014 | 1258 | 0.090 |
Why?
|
Pregnancy | 4 | 2022 | 30258 | 0.090 |
Why?
|
Genome, Human | 2 | 2014 | 4448 | 0.090 |
Why?
|
Education, Medical, Continuing | 1 | 2015 | 830 | 0.090 |
Why?
|
Histocompatibility Testing | 2 | 2009 | 726 | 0.080 |
Why?
|
Delphi Technique | 1 | 2013 | 893 | 0.080 |
Why?
|
Canada | 1 | 2014 | 2119 | 0.080 |
Why?
|
United States | 6 | 2022 | 72898 | 0.080 |
Why?
|
Kruppel-Like Transcription Factors | 3 | 2007 | 506 | 0.080 |
Why?
|
Biostatistics | 1 | 2010 | 162 | 0.080 |
Why?
|
STAT1 Transcription Factor | 3 | 1999 | 339 | 0.080 |
Why?
|
Vanadates | 2 | 1999 | 82 | 0.080 |
Why?
|
Quality Assurance, Health Care | 2 | 2017 | 2172 | 0.080 |
Why?
|
Epitopes | 1 | 2015 | 2523 | 0.080 |
Why?
|
Europe | 1 | 2014 | 3423 | 0.070 |
Why?
|
Coronary Artery Bypass | 1 | 2017 | 2186 | 0.070 |
Why?
|
Histocompatibility | 1 | 2009 | 327 | 0.070 |
Why?
|
Receptors, Complement 3b | 1 | 2007 | 124 | 0.070 |
Why?
|
Macrocyclic Compounds | 1 | 2007 | 68 | 0.070 |
Why?
|
Coloring Agents | 1 | 2010 | 564 | 0.070 |
Why?
|
Erythroblasts | 1 | 2007 | 142 | 0.070 |
Why?
|
Program Evaluation | 1 | 2016 | 2499 | 0.070 |
Why?
|
Staurosporine | 2 | 1999 | 240 | 0.070 |
Why?
|
Plasma | 1 | 2010 | 579 | 0.070 |
Why?
|
Blood Cells | 1 | 2008 | 307 | 0.070 |
Why?
|
Students, Medical | 2 | 2018 | 1959 | 0.070 |
Why?
|
Learning | 1 | 2016 | 1755 | 0.070 |
Why?
|
Plasmapheresis | 1 | 2007 | 205 | 0.070 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2021 | 4058 | 0.060 |
Why?
|
Pediatrics | 1 | 2021 | 3606 | 0.060 |
Why?
|
Medical Order Entry Systems | 1 | 2011 | 521 | 0.060 |
Why?
|
Immunoglobulin Light Chains | 1 | 2007 | 290 | 0.060 |
Why?
|
Female | 14 | 2024 | 396101 | 0.060 |
Why?
|
Adult | 10 | 2024 | 223038 | 0.060 |
Why?
|
Mycophenolic Acid | 1 | 2007 | 346 | 0.060 |
Why?
|
Germ-Line Mutation | 1 | 2014 | 1884 | 0.060 |
Why?
|
Training Support | 1 | 2006 | 109 | 0.060 |
Why?
|
Attitude | 1 | 2010 | 770 | 0.060 |
Why?
|
Resource Allocation | 1 | 2008 | 354 | 0.060 |
Why?
|
Myeloablative Agonists | 1 | 2006 | 215 | 0.060 |
Why?
|
Cardiology | 1 | 2016 | 1702 | 0.060 |
Why?
|
Chimerism | 1 | 2006 | 154 | 0.060 |
Why?
|
Young Adult | 6 | 2024 | 59886 | 0.060 |
Why?
|
Retrospective Studies | 6 | 2024 | 81515 | 0.060 |
Why?
|
Practice Guidelines as Topic | 2 | 2014 | 7425 | 0.060 |
Why?
|
Bone Marrow Cells | 2 | 2008 | 2412 | 0.060 |
Why?
|
Transplantation Conditioning | 2 | 2010 | 1635 | 0.050 |
Why?
|
Alleles | 1 | 2015 | 6897 | 0.050 |
Why?
|
Sequence Analysis, DNA | 1 | 2014 | 4772 | 0.050 |
Why?
|
ADAM Proteins | 1 | 2005 | 242 | 0.050 |
Why?
|
Evidence-Based Practice | 1 | 2008 | 500 | 0.050 |
Why?
|
Publishing | 1 | 2010 | 835 | 0.050 |
Why?
|
Boston | 2 | 2014 | 9338 | 0.050 |
Why?
|
Immunoglobulin G | 1 | 2015 | 4528 | 0.050 |
Why?
|
Male | 12 | 2024 | 363691 | 0.050 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2006 | 791 | 0.050 |
Why?
|
Middle Aged | 10 | 2024 | 223004 | 0.050 |
Why?
|
Antigens | 1 | 2007 | 1438 | 0.050 |
Why?
|
Chemokine CCL2 | 1 | 2004 | 602 | 0.050 |
Why?
|
Thromboembolism | 1 | 2008 | 1003 | 0.050 |
Why?
|
Gram-Negative Bacteria | 1 | 2023 | 275 | 0.050 |
Why?
|
Renal Insufficiency | 1 | 2007 | 804 | 0.050 |
Why?
|
Prevalence | 2 | 2015 | 15839 | 0.040 |
Why?
|
Attitude of Health Personnel | 1 | 2014 | 3925 | 0.040 |
Why?
|
Monosaccharide Transport Proteins | 1 | 2002 | 437 | 0.040 |
Why?
|
Adolescent | 3 | 2024 | 88832 | 0.040 |
Why?
|
Genotype | 1 | 2015 | 13024 | 0.040 |
Why?
|
Mutagenesis, Site-Directed | 2 | 2002 | 1679 | 0.040 |
Why?
|
Aged | 6 | 2024 | 171114 | 0.040 |
Why?
|
Vasculitis | 1 | 2004 | 527 | 0.040 |
Why?
|
Interferon-gamma | 2 | 1999 | 3160 | 0.040 |
Why?
|
Combined Modality Therapy | 1 | 2011 | 8529 | 0.040 |
Why?
|
Career Choice | 1 | 2006 | 769 | 0.040 |
Why?
|
Phosphorylation | 3 | 1999 | 8278 | 0.040 |
Why?
|
Transfection | 3 | 2004 | 5743 | 0.040 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2002 | 852 | 0.040 |
Why?
|
Monocytes | 1 | 2007 | 2595 | 0.040 |
Why?
|
Muscle Proteins | 1 | 2002 | 1158 | 0.030 |
Why?
|
Leupeptins | 1 | 1996 | 112 | 0.030 |
Why?
|
Aged, 80 and over | 2 | 2015 | 59488 | 0.030 |
Why?
|
Protein Biosynthesis | 1 | 2004 | 2086 | 0.030 |
Why?
|
Receptors, Interferon | 1 | 1996 | 114 | 0.030 |
Why?
|
Gene Expression Regulation | 3 | 2004 | 11888 | 0.030 |
Why?
|
Phosphotyrosine | 1 | 1996 | 459 | 0.030 |
Why?
|
Cell Division | 1 | 2023 | 4475 | 0.030 |
Why?
|
Acetylcysteine | 1 | 1996 | 262 | 0.030 |
Why?
|
Immunosuppressive Agents | 1 | 2007 | 4209 | 0.030 |
Why?
|
Cell Line | 4 | 2004 | 15543 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2010 | 10383 | 0.030 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 1996 | 1724 | 0.030 |
Why?
|
Cysteine Endopeptidases | 1 | 1996 | 542 | 0.030 |
Why?
|
Adipose Tissue | 2 | 2002 | 3312 | 0.030 |
Why?
|
Plateletpheresis | 1 | 2013 | 39 | 0.030 |
Why?
|
Multienzyme Complexes | 1 | 1996 | 663 | 0.030 |
Why?
|
Uterine Hemorrhage | 1 | 2014 | 235 | 0.030 |
Why?
|
Transcription Factors | 2 | 2002 | 12131 | 0.030 |
Why?
|
Transcription, Genetic | 3 | 2004 | 7599 | 0.030 |
Why?
|
CCAAT-Enhancer-Binding Protein-alpha | 2 | 2002 | 130 | 0.020 |
Why?
|
Organizational Policy | 1 | 2014 | 434 | 0.020 |
Why?
|
Kinetics | 1 | 1999 | 6274 | 0.020 |
Why?
|
Time Factors | 3 | 2013 | 40065 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2008 | 8041 | 0.020 |
Why?
|
Cryopreservation | 1 | 2016 | 728 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2002 | 2968 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2007 | 15398 | 0.020 |
Why?
|
Congresses as Topic | 1 | 2016 | 811 | 0.020 |
Why?
|
Unnecessary Procedures | 1 | 2014 | 416 | 0.020 |
Why?
|
Escherichia coli | 1 | 2023 | 4214 | 0.020 |
Why?
|
Algorithms | 1 | 2011 | 14071 | 0.020 |
Why?
|
Neutrophils | 2 | 2016 | 3776 | 0.020 |
Why?
|
Blood Loss, Surgical | 1 | 2014 | 629 | 0.020 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 1996 | 1314 | 0.020 |
Why?
|
Protein-Tyrosine Kinases | 1 | 1999 | 2423 | 0.020 |
Why?
|
Immunization | 1 | 2014 | 1219 | 0.020 |
Why?
|
Cell Differentiation | 1 | 2007 | 11640 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 1999 | 6493 | 0.020 |
Why?
|
Bacterial Proteins | 1 | 2023 | 3837 | 0.020 |
Why?
|
Tissue Donors | 2 | 2010 | 2395 | 0.020 |
Why?
|
Teaching | 1 | 2017 | 1169 | 0.020 |
Why?
|
Blotting, Western | 1 | 1996 | 5020 | 0.020 |
Why?
|
Color | 1 | 2010 | 299 | 0.020 |
Why?
|
Transcriptional Activation | 2 | 2007 | 1744 | 0.020 |
Why?
|
Dysmenorrhea | 1 | 2010 | 104 | 0.020 |
Why?
|
Promoter Regions, Genetic | 3 | 2007 | 5786 | 0.020 |
Why?
|
Cell Cycle Proteins | 1 | 1999 | 3430 | 0.020 |
Why?
|
Hematopoietic System | 1 | 2007 | 110 | 0.020 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 1 | 1993 | 820 | 0.020 |
Why?
|
Myeloid Progenitor Cells | 1 | 2007 | 112 | 0.020 |
Why?
|
Transplantation Immunology | 1 | 2009 | 541 | 0.020 |
Why?
|
Fibroblasts | 1 | 1996 | 4159 | 0.020 |
Why?
|
Enzyme Inhibitors | 1 | 1996 | 3715 | 0.020 |
Why?
|
Mice | 6 | 2007 | 81818 | 0.020 |
Why?
|
Nuclear Proteins | 2 | 1999 | 5783 | 0.020 |
Why?
|
DNA | 3 | 2007 | 7202 | 0.020 |
Why?
|
Vidarabine | 1 | 2007 | 343 | 0.020 |
Why?
|
Autoimmunity | 1 | 2013 | 1354 | 0.020 |
Why?
|
Melphalan | 1 | 2007 | 425 | 0.020 |
Why?
|
Survival Analysis | 2 | 2009 | 10070 | 0.020 |
Why?
|
Neoplasms | 1 | 2014 | 22340 | 0.010 |
Why?
|
Antilymphocyte Serum | 1 | 2007 | 493 | 0.010 |
Why?
|
Signal Transduction | 2 | 1999 | 23600 | 0.010 |
Why?
|
Hysterectomy | 1 | 2010 | 864 | 0.010 |
Why?
|
Cell Count | 1 | 2009 | 1823 | 0.010 |
Why?
|
T-Lymphocyte Subsets | 1 | 1993 | 1811 | 0.010 |
Why?
|
Clinical Laboratory Techniques | 1 | 2010 | 747 | 0.010 |
Why?
|
Animals | 8 | 2010 | 168759 | 0.010 |
Why?
|
Vaccines | 1 | 1993 | 841 | 0.010 |
Why?
|
Guideline Adherence | 1 | 2014 | 2243 | 0.010 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 1993 | 2570 | 0.010 |
Why?
|
Membrane Glycoproteins | 1 | 2014 | 3690 | 0.010 |
Why?
|
Rabbits | 1 | 2010 | 4734 | 0.010 |
Why?
|
Smad3 Protein | 1 | 2004 | 164 | 0.010 |
Why?
|
Child | 2 | 2022 | 80563 | 0.010 |
Why?
|
CCAAT-Enhancer-Binding Protein-delta | 1 | 2002 | 26 | 0.010 |
Why?
|
CCAAT-Enhancer-Binding Protein-beta | 1 | 2002 | 102 | 0.010 |
Why?
|
Myogenic Regulatory Factors | 1 | 2002 | 99 | 0.010 |
Why?
|
Sterol Regulatory Element Binding Protein 1 | 1 | 2002 | 135 | 0.010 |
Why?
|
Transcription Factor AP-1 | 1 | 2004 | 322 | 0.010 |
Why?
|
Glucose Transporter Type 4 | 1 | 2002 | 240 | 0.010 |
Why?
|
Tunica Intima | 1 | 2004 | 455 | 0.010 |
Why?
|
CCAAT-Enhancer-Binding Proteins | 1 | 2002 | 287 | 0.010 |
Why?
|
Guidelines as Topic | 1 | 2008 | 1394 | 0.010 |
Why?
|
Luciferases | 1 | 2002 | 713 | 0.010 |
Why?
|
Macrophage Activation | 1 | 2004 | 552 | 0.010 |
Why?
|
3T3 Cells | 1 | 2002 | 1081 | 0.010 |
Why?
|
Hyperplasia | 1 | 2004 | 1144 | 0.010 |
Why?
|
Treatment Failure | 1 | 2007 | 2652 | 0.010 |
Why?
|
Retroviridae | 1 | 2002 | 847 | 0.010 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2004 | 637 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2010 | 6832 | 0.010 |
Why?
|
DNA, Complementary | 1 | 2002 | 1984 | 0.010 |
Why?
|
Amino Acid Sequence | 2 | 2002 | 13400 | 0.010 |
Why?
|
CREB-Binding Protein | 1 | 1999 | 146 | 0.010 |
Why?
|
Tissue Distribution | 1 | 2002 | 2266 | 0.010 |
Why?
|
Cell Lineage | 1 | 2007 | 2573 | 0.010 |
Why?
|
Molecular Sequence Data | 2 | 2002 | 17594 | 0.010 |
Why?
|
Blood Platelets | 1 | 2009 | 2464 | 0.010 |
Why?
|
Schizosaccharomyces pombe Proteins | 1 | 1999 | 177 | 0.010 |
Why?
|
Patient Care Team | 1 | 2008 | 2517 | 0.010 |
Why?
|
Transforming Growth Factor beta | 1 | 2004 | 1995 | 0.010 |
Why?
|
Adipocytes | 1 | 2002 | 1194 | 0.010 |
Why?
|
Ligands | 1 | 2002 | 3273 | 0.010 |
Why?
|
Societies, Medical | 1 | 2008 | 3956 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2002 | 4562 | 0.010 |
Why?
|
Serine | 1 | 1999 | 824 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 1 | 2004 | 3737 | 0.010 |
Why?
|
Mutagenesis | 1 | 1999 | 1228 | 0.010 |
Why?
|
Protein Binding | 1 | 2007 | 9296 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 1993 | 10261 | 0.010 |
Why?
|
Fungal Proteins | 1 | 1999 | 899 | 0.010 |
Why?
|
Proto-Oncogene Proteins | 1 | 2007 | 4520 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 1999 | 2745 | 0.010 |
Why?
|
Tyrosine | 1 | 1999 | 1428 | 0.010 |
Why?
|
Biological Transport | 1 | 1999 | 2081 | 0.010 |
Why?
|
Point Mutation | 1 | 1999 | 1590 | 0.010 |
Why?
|
Decision Making | 1 | 2008 | 3965 | 0.010 |
Why?
|
Models, Genetic | 1 | 2002 | 3448 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2007 | 12769 | 0.010 |
Why?
|
Research Design | 1 | 2008 | 6208 | 0.010 |
Why?
|
Mice, Inbred DBA | 1 | 1993 | 623 | 0.010 |
Why?
|
Drosophila | 1 | 1999 | 1501 | 0.010 |
Why?
|
Rats | 1 | 2007 | 23707 | 0.010 |
Why?
|
Lymphocyte Depletion | 1 | 1993 | 605 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2007 | 17075 | 0.010 |
Why?
|
Binding Sites | 1 | 1999 | 6001 | 0.010 |
Why?
|
Glucose | 1 | 2002 | 4335 | 0.010 |
Why?
|
Mice, Inbred Strains | 1 | 1993 | 1770 | 0.010 |
Why?
|
Heart Transplantation | 1 | 2004 | 3310 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2016 | 65189 | 0.010 |
Why?
|
Delivery of Health Care | 1 | 2008 | 5369 | 0.010 |
Why?
|
Phenotype | 1 | 2007 | 16721 | 0.010 |
Why?
|
Proteins | 1 | 2004 | 5995 | 0.000 |
Why?
|
Macrophages | 1 | 2004 | 5772 | 0.000 |
Why?
|
Cryptococcus neoformans | 1 | 1949 | 110 | 0.000 |
Why?
|
Cryptococcosis | 1 | 1949 | 99 | 0.000 |
Why?
|
Mice, Knockout | 1 | 2004 | 14447 | 0.000 |
Why?
|
Muscle, Skeletal | 1 | 2002 | 4959 | 0.000 |
Why?
|
Cells, Cultured | 1 | 2002 | 18973 | 0.000 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2007 | 11868 | 0.000 |
Why?
|
Mice, Inbred C57BL | 1 | 2004 | 22331 | 0.000 |
Why?
|
Antibodies | 1 | 1993 | 2417 | 0.000 |
Why?
|
Lymphocyte Activation | 1 | 1993 | 5501 | 0.000 |
Why?
|
Postoperative Complications | 1 | 2004 | 15747 | 0.000 |
Why?
|
Lymph Nodes | 1 | 1993 | 3454 | 0.000 |
Why?
|